ClinicalTrials.Veeva

Menu

Standardized Goal-Directed Vs. Self-Directed Valsalva Maneuver for the Assessment of Patent Foramen Ovale

U

University of Ottawa Heart Institute

Status

Enrolling

Conditions

Stroke

Treatments

Device: Control - standard of care: Self-Directed Valsalva maneuver
Device: Experimental: Intervention arm: Goal-Directed Valsalva maneuver

Study type

Interventional

Funder types

Other

Identifiers

NCT06670781
OHSN CRRF ID - 6016

Details and patient eligibility

About

Ischemic stroke represents a major public health issue, leading to significant disabilities and deaths worldwide. When no clear cause for stroke is found following a comprehensive cardiovascular evaluation (no atrial fibrillation, cardiac masses, or atherosclerosis) i.e. cryptogenic stroke, it is recommended to search for a patent foramen ovale (PFO), especially in young patients. It is estimated that cryptogenic stroke accounts for 30% to 40% of ischemic strokes. Transthoracic echocardiography (TTE) with bubble study at rest and during Valsalva maneuver is the reference method for the diagnosis of PFO. The treatment of PFO using a closure device has demonstrated a significant reduction in recurrent stroke events in patients with PFO and cryptogenic stroke. The Valsalva maneuver is currently achieved using self-directed maneuver i.e. patients are instructed to ''bear down'' or ''strain as if attempting to move your bowels.'' These instructions are subjective and depend largely on individuals understanding and effort. A Goal-Directed Valsalva Maneuver using a manometer has been shown to be a more reproducible way to perform the Valsalva achieving more sensitivity in different settings such as hypertrophic cardiomyopathy but its incremental diagnostic value for the detection of PFO has not been yet evaluated.

The aim of the present study is to compare the sensibility and specificity of two methods of Valsalva maneuver for the detection of PFO. We hypothesize that Goal-Directed Valsalva Maneuver will significantly increase the detection rate of PFO compared to Self-Directed Valsalva Maneuver.

Enrollment

488 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients referred for a clinically indicated TTE and bubble study

Exclusion criteria

  • Inability to provide informed consent
  • Inability to insert an IV line
  • Inability to perform a Self-Directed Valsalva maneuver
  • Patient wishing to keep his mask on

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

488 participants in 2 patient groups

Control - standard of care: Self-Directed Valsalva maneuver
Sham Comparator group
Description:
The Valsalva maneuver is performed by the patient taking a normal (or deep) inspiration, followed by forceful expiration against a closed airway for up to 15 to 20 sec and then release of the expiratory effort on entry of saline into the right atrium.
Treatment:
Device: Experimental: Intervention arm: Goal-Directed Valsalva maneuver
Device: Control - standard of care: Self-Directed Valsalva maneuver
Intervention arm: Goal-Directed Valsalva maneuver
Active Comparator group
Description:
For the Goal directed Valsalva maneuver, the same method patients are instructed to blow into a plastic pipe connected to the manometer device, in order to reach a pressure of 40 mmHg for at least 5 seconds. Then patients are instructed to exhale quickly.
Treatment:
Device: Experimental: Intervention arm: Goal-Directed Valsalva maneuver
Device: Control - standard of care: Self-Directed Valsalva maneuver

Trial contacts and locations

1

Loading...

Central trial contact

Dr. David Messika-Zeitoun, MD; Roja Gauda, Masters of Applied Science

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems